Video Center


The OBR Video Center Features educational videos covering a wide range of oncology specific topics.

Nevena Damjanov, MD, on impressions of the study combining cabozantinib with checkpoint inhibitors in advanced HCC patients

Dr. Damjanov, Director of Gastrointestinal Oncology, University of Pennsylvania, on her impressions of the study presented at ASCO which combines cabozantinib with checkpoint inhibitors in advanced HCC patients

Tags: ASCO GI Conference CoverageLiver (includes HCC, Billiary Tract)

Published: 25 January 2020

Recent Videos

video

Una Hopkins, RN, DNP, FNP-BC, shares how immuno-oncology clinical trials differ from other clinical trials

Uma Hopkins, Director of Research, Montefiore Health System, shares how immuno-oncology clinical trials differ from other clinical trials and potential ...

video

Gitesh Patel, on domains that indicate the unmet need in digital health technologies

Gitesh Patel, Director of Business Development, Comprehensive Blood and Cancer Centers, on domains that are most interesting to attendees at ...

video

Gitesh Patel, shares details on the digital health landscape study presented at ACCC '20

Gitesh Patel, Director of Business Development, Comprehensive Blood and Cancer Centers, shares details on the digital health landscape study presented ...

video

Ali McBride, PharmD, MS, BCOP, FASHP, on lessons from his year as ACCC president to share with oncology stakeholders

Ali McBride, Clinical Assistant Professor, University of Arizona College of Pharmacy, on lessons from his year as ACCC president to ...

video

Melody Chang, RPh, MBA, BCOP, explains biosimilars' impact on economics in 340B hospitals and non 340B hospitals

Melody Chang, Director of Pharmacy Operations, Florida Cancer Specialists, explains biosimilars' impact on economics in 340B hospitals and non 340B ...

video

Melody Chang, RPh, MBA, BCOP, shares thoughts on 340B reform to benefit cancer care providers and patients

Melody Chang, Director of Pharmacy Operations, Florida Cancer Specialists, shares thoughts on 340B reform to benefit cancer care providers and ...

video

Melody Chang, RPh, MBA, BCOP, shares how 340B is affecting pharmacy operations at Florida Cancer Specialists

Melody Chang, Director of Pharmacy Operations, Florida Cancer Specialists, shares how 340B is affecting pharmacy operations at Florida Cancer Specialists

video

Una Hopkins, RN, DNP, FNP-BC, regarding cancer survivorship resulting from expanded use of immune-oncology agents

Uma Hopkins, Director of Research, Montefiore Health System, regarding the change in cancer survivorship resulting from expanded use of immune-oncology ...

video

Anne Hubbard, MBA, regarding the new radiation oncology payment model and its affect on economics

Anne Hubbard, Director of Health Policy, American Society for Radiation Oncology, regarding the new radiation oncology payment model and how ...

video

Anne Hubbard, MBA, shares concerns regarding new Radiation Oncology payment methodology proposed in the Radiation Oncology payment model

Anne Hubbard, Director of Health Policy, American Society for Radiation Oncology, shares concerns regarding new Radiation Oncology payment methodology proposed ...

Related Videos

video-image

Una Hopkins, RN, DNP, FNP-BC, regarding cancer survivorship resulting from expanded use of immune-oncology agents

video-image

Mike Koroscik, MHA, MBA, describes strategies that successfully prevent ED visits by cancer patients

video-image

Erich A. Mounce, MSHA, shares ways OneOncology has evolved since its inception 18 months ago

video-image

Melody Chang, RPh, MBA, BCOP, shares how 340B is affecting pharmacy operations at Florida Cancer Specialists

video-image

Linda Bosserman, MD, FACP, FASCO, describes cancer patient populations that may benefit form TeleHealth

video-image

Lalan S. Wilfong, MD, explains how private insurance Alternative Payment Models differ form Oncology Care Models or other Alternative Payment Models CMS is offering

video-image

Melody Chang, RPh, MBA, BCOP, shares thoughts on 340B reform to benefit cancer care providers and patients

video-image

Linda Bosserman, MD, FACP, FASCO, on TeleHealth models to position cancer centers to deliver high quality care

video-image

Lalan S. Wilfong, MD, describes CMMI's proposed Oncology Care First model and how it differs from OCM

video-image

Melody Chang, RPh, MBA, BCOP, explains biosimilars' impact on economics in 340B hospitals and non 340B hospitals

video-image

Linda Bosserman, MD, FACP, FASCO, on if TeleHealth will effectively deliver follow up care for cancer therapies

video-image

Lalan S. Wilfong, MD, explains his practice's decision to embrace 2 sided risk and advice for practices

video-image

Ali McBride, PharmD, MS, BCOP, FASHP, on lessons from his year as ACCC president to share with oncology stakeholders

video-image

Erich Mounce, MSHA, summarized types of practice setting available to community oncologists

video-image

Barbara McAneny, MD, FASCO, MACP, explains New Mexico Hem/Onc's decision to remain independent and its outcomes

video-image

Gitesh Patel, shares details on the digital health landscape study presented at ACCC '20

video-image

Erich Mounce, MSHA, explains when an independent community practice should join a larger network

video-image

Barbara McAneny, MD, FASCO, MACP, on whether New Mexico Hem/Onc are embracing two-sided risk and the rational

video-image

Gitesh Patel, on domains that indicate the unmet need in digital health technologies

video-image

Erich Mounce, MSHA, on what an oncologist should consider when moving to a different setting